A device may receive medical data associated with potential patients for a clinical trial of a drug, where the medical data includes one or more of multi-omics data associated with the potential patients, genomic profiles of the potential patients, dosage and time associated with the drug, electronic medical records of the potential patients, or clinical trial data associated with the drug. The device may perform, in parallel, a topological data analysis, a non-matrix factorization analysis, and a neural network analysis of the medical data. The device may identify a group of patients, of the potential patients, for the clinical trial of the drug based on performing the topological data analysis, the non-matrix factorization analysis, and the neural network analysis of the medical data, and may provide information identifying the group of patients.